| Name | Title | Contact Details |
|---|---|---|
Gary Baldwin |
Chief Technology Officer | Profile |
Bioventus®Inc. (Nasdaq: BVS) develops Innovations for Active Healing and its mission is to make a difference by helping patients resume and enjoy active lives. The Company has products for pain treatment & joint preservation, restorative therapies and bone graft substitutes. Established in 2012, Bioventus is headquartered in Durham, NC. The company has more than 800 employees worldwide and its international headquarters is in Hoofddorp, The Netherlands. Bioventus also has offices in Memphis, TN, Valencia, CA, Hod Hasharon, Israel and Mississauga, Ontario, Canada. Bioventus works with patients, payers and health care providers throughout the world.
Titan Medical Inc. is a Canadian public company, headquartered in Toronto, Ontario, and listed on the Toronto Stock Exchange (TMD) and on NASDAQ in the United States (TMDI). Titan is focused on the design, development and commercialization of novel advanced robotic surgical technologies such as SPORT(TM) Surgical System. Titan`s SPORT Surgical System is a versatile single incision advanced robotic platform that features state-of the-art multi-articulated instruments with unique replaceable tips, 3D visualization on High Definition flat-screen monitor, highly ergonomic open workstation with natural surgeon interface and a single low-profile patient cart for ease of set up that enables broad applications of single and multi-quadrant surgeries. The SPORT Surgical System`s smart design elements are geared with the specific goals of delivering superior clinical capabilities and unparalleled OR efficiency at the operating costs similar to Laparoscopic Surgery in mind. Titan Medical Inc. is focused on delivering the promise of Robotic Surgery Optimized. SPORT Surgical System is currently not cleared by FDA or doesn`t have the CE mark.
Neocis is transforming dental implant surgery with advanced robotics. The company is focused on enhancing dental surgeons` capabilities and advancing patient care through the latest technology.
Profusa, Inc. is leading the development of a new generation of biologically integrated sensors that empowers an individual with the ability to continuously monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. Overcoming the bodys response to foreign material, the companys technology enables the development of minute bioengineered sensors that become one with the body to detect and transmit clinical-grade data for personal and medical use.
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.